Picture3.jpg
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
March 19, 2024 07:55 ET | Clearmind Medicine Inc.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
image1 (1).png
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
March 19, 2024 07:30 ET | Evaxion Biotech
The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes...
Repligen_Logo-HORIZONTAL-withtagline (1).jpg
Repligen Appoints Maggie A. Pax to Board of Directors
March 19, 2024 07:30 ET | Repligen Corporation
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax....
InflaRx on large white.jpg
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
March 19, 2024 07:30 ET | InflaRx N.V.
JENA, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
formulalogo.jpg
Formula Systems Reports Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024 07:08 ET | Formula Systems (1985) Ltd.
OR YEHUDA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Or Yehuda, Israel, March 19, 2024 – Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information...
Gilat Logo Full Color.png
Gilat Unveils Cloud and 5G NTN Evolution Strategy for SkyEdge IV
March 19, 2024 07:05 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Century_PrimaryLogo_pfade_RGB_RZ.png
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024 07:00 ET | Century Therapeutics, Inc.
PHILADELPHIA, March 19, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...
Axsome Logo.png
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
March 19, 2024 07:00 ET | Axsome Therapeutics, Inc.
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Tourmaline_logo.jpg
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
March 19, 2024 07:00 ET | Tourmaline Bio, Inc.
– Initiated pivotal spiriTED Phase 2b trial in Thyroid Eye Disease (TED) in 2023 and expanded TED clinical development plan, including accelerating the planned initiation of a pivotal Phase 3 trial...
logo.jpg
Beamr presents accelerated video AI workflows at NVIDIA GTC
March 19, 2024 07:00 ET | Beamr Imaging Ltd.
Herzliya Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced it will present accelerated video AI...